Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Sunshine Biopharma (SBFM) over the last 15 years, with Dec 2024 value amounting to $207,167.

  • Sunshine Biopharma's Other Working Capital Changes rose 56.81% to -$36,168 in Q3 2025 from the same period last year, while for Sep 2025 it was $166,842, marking a year-over-year increase of 841.07%. This contributed to the annual value of $207,167 for FY2024, which is 879.84% up from last year.
  • According to the latest figures from FY2024, Sunshine Biopharma's Other Working Capital Changes is $207,167, which was up 879.84% from $21,143 recorded in FY2023.
  • Sunshine Biopharma's Other Working Capital Changes' 5-year high stood at $207,167 during FY2024, with a 5-year trough of -$82,846 in FY2022.
  • Moreover, its 3-year median value for Other Working Capital Changes was $21,143 (2023), whereas its average is $48,488.
  • In the last 5 years, Sunshine Biopharma's Other Working Capital Changes soared by 1,662.77% in 2021 and then plummeted by 408.59% in 2022.
  • Over the past 5 years, Sunshine Biopharma's Other Working Capital Changes (Yearly) stood at $1,523 in 2020, then surged by 1,662.77% to $26,847 in 2021, then tumbled by 408.59% to -$82,846 in 2022, then soared by 125.52% to $21,143 in 2023, then surged by 879.84% to $207,167 in 2024.